EXPLORE
The pace of clinical progress may be slow; but the pace of knowledge accumulation is not. Two decades of molecular research have greatly enhanced our understanding of glioblastoma. Yet we still write as though the problem were simply missing information. The next advance will likely come from connecting pieces we already have-
